Policy Notices

• Publication of the Revised NIH Grants Policy Statement (Rev. December 2022) for Fiscal Year 2023
  (NOT-OD-23-045)
  National Institutes of Health
  

• Updates to the Non-Discrimination Legal Requirements for NIH Recipients
  (NOT-OD-23-047)
  National Institutes of Health
  

• NIH Operates Under a Continuing Resolution
  (NOT-OD-23-050)
  National Institutes of Health
  

General Notices

• Notice to Extend the Response Date for NOT-CA-23-007, "Request for Information (RFI): Soliciting Input on the Use and Reuse of Cancer Metabolomics Data"
  (NOT-CA-23-027)
  National Cancer Institute
  

• Notice of Pre-Application Technical Assistance Webinar for RFA-DA-23-060 and RFA-DA-23-059, "HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program"
  (NOT-DA-22-086)
  National Institute on Drug Abuse
  

• Notice of Early Expiration of PAR-20-100 Genomic Community Resources (U24 Clinical Trial Not Allowed)
  (NOT-HG-23-016)
  National Human Genome Research Institute
  

• NHLBI Announces New Policies Regarding Budget Guidelines for SBIR/STTR Applications
  (NOT-HL-22-065)
  National Heart, Lung, and Blood Institute
  

• Findings of Research Misconduct
  (NOT-OD-23-048)
  Office of the Director, NIH
  

• Notice of Pre-Application Webinar for PAR-23-045, Biomedical Research Facilities (C06 CT NA)
  (NOT-OD-23-049)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Notice of Changes to Funding Opportunities

• Notice to Correct and Clarify Eligibility Requirements in PAR-21-306, NCI Research Specialist (Clinical Scientist) Award (R50 Clinical Trial Not Allowed)
  (NOT-CA-23-026)
  National Cancer Institute
  

• Notice of Additional Receipt Date and Update of Allowable Resubmission Applications for RFA-DK-22-039, "Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
  (NOT-DK-23-005)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Early Expiration of PAR-20-089 "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"
  (NOT-GM-23-029)
  National Institute of General Medical Sciences
  

• Notice of Early Expiration of PAR-20-097 "Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)"
  (NOT-GM-23-030)
  National Institute of General Medical Sciences
  

• Notice of Participation of NIMH in PAR-23-030, "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)"
  (NOT-MH-23-155)
  National Institute of Mental Health
  

• Notice of Early Expiration of RFA-NS-21-022 "Translational Neural Devices (U44 Clinical Trial Optional)"
  (NOT-NS-23-055)
  National Institute of Neurological Disorders and Stroke
  

Requests for Proposal

• Broad Agency Announcement (BAA): Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices, BAA-75N93022R00021
  (NOT-AI-23-006)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
  (NOT-MD-23-001)
  National Institute on Minority Health and Health Disparities
  National Institute on Drug Abuse
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): BRAIN Initiative: Developing Data Archive, Informatics Tools and Data Standards for Brain Behavior Quantification and Synchronization (BBQS)
  (NOT-MH-23-115)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
  (NOT-OD-23-040)
  Office of the Director, NIH
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Library of Medicine
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Research Supplements to Promote Data Science Workforce Diversity to Reveal Scientific Insights of COVID-19 Testing Technologies (Admin Supp Clinical Trial Not Allowed)
  (NOT-OD-23-041)
  Office of the Director, NIH
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  

Funding Opportunities

• Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
  (PAR-23-045)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): February 24, 2023
  
  

• Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
  (PAR-23-063)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 28, 2025
  
  

• Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
  (PAR-23-075)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)
  (PAR-23-078)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 08, 2023
  
  

• Biomedical Data Repository (U24 - Clinical Trials Not Allowed)
  (PAR-23-079)
  National Institute of General Medical Sciences
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 08, 2023
  
  

• Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
  (PAR-23-081)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
  (PAR-23-083)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Genomic Community Resources (U24 Clinical Trial Not Allowed)
  (PAR-23-085)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): January 25, 2023
  
  

• Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed)
  (RFA-AG-24-024)
  National Institute on Aging
  Application Receipt Date(s): February 03, 2023
  
  

• Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed)
  (RFA-AI-22-070)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 19, 2023
  
  

• Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required)
  (RFA-AI-22-071)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 19, 2023
  
  

• Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
  (RFA-CA-23-014)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2023
  
  

• Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
  (RFA-CA-23-015)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2023
  
  

• Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-23-016)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2023
  
  

• Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-23-017)
  National Cancer Institute
  Application Receipt Date(s): November 17, 2023
  
  

• Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Not Allowed)
  (RFA-DK-22-023)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed.
  (RFA-FD-23-007)
  Food and Drug Administration
  Application Receipt Date(s): March 07, 2023
  
  

• Cooperative Agreement to Support the Western Center for Food Safety (U19) Clinical Trials Not Allowed
  (RFA-FD-23-021)
  Food and Drug Administration
  Application Receipt Date(s): March 3, 2023, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
  
  

• BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)
  (RFA-MH-23-335)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Enhancing the Use of the All of Us Research Programs Data (R21 Clinical Trial Not Allowed)
  (RFA-PM-23-001)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of AIDS Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  Application Receipt Date(s): March 01, 2023
  
  

• Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed)
  (RFA-PM-23-002)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of AIDS Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  Application Receipt Date(s): March 01, 2023